Reflecting on the Year in Cancer Care: Progress, Hope, and What’s Ahead

by | Dec 30, 2025 | Uncategorized | 0 comments

As we close out the year, it’s a good time to reflect on how far cancer care has come, and what’s still ahead. The field of oncology is evolving rapidly, and patients, caregivers, and care teams alike benefit from understanding the progress, the hope it brings, and the directions we’re heading.

Major Advances in Treatment and Research

  1. More new therapies approved

Between July 1, 2024, and June 30, 2025, the American Association for Cancer Research (AACR) reports that the U.S. Food and Drug Administration approved 20 new anticancer therapeutics and two new devices. One device for treating lung cancer and one for cervical cancer screenings, along with expanding the use of 8 previously approved anticancer therapeutics.

  1. Survival is improving

The number of cancer survivors in the U.S. is projected to reach approximately 18.6 million this year, with an expected rise to more than 22 million by 2035.

  1. Precision medicine and immunotherapy are expanding

Precision oncology, molecular profiling, and immunotherapy are offering more personalized treatment options, changing how we think about “one-size-fits-all.”

  1. Technology and data are enhancing care delivery

Advances in artificial intelligence, machine learning, and multimodal data are helping create smarter diagnostics and treatment planning.

 

Why Hope Matters, and What It Means for Patients

Hope isn’t just an emotion; it represents tangible change in care, more treatment options, and better outcomes. For patients and families, this means earlier detection, fewer side-effects, improved quality of life, and greater involvement in decisions. At our community oncology practice, hope translates into our daily work to bring advanced care closer to home and make it personal and meaningful.

Challenges Still to Overcome

While progress is real, there are still important gaps and issues:

  • Disparities in care access remain a concern. Certain racial, minority, and medically underserved populations continue to bear a disproportionate burden of cancer.
  • Clinical trial enrollment and availability still limit how many patients can access emerging treatments.
  • Preventative care and early detection still lag behind in some cancer types and populations, meaning many cancers are still diagnosed late.
  • Sustainable research funding and resource allocation will be vital to maintain momentum.

What’s Ahead: What to Watch For

Looking into 2026 and beyond, here are some key areas that may shape cancer care:

  • Broader use of liquid biopsies and multi-cancer early detection tests, helping find cancer earlier when treatment is more effective.
  • Expansion of personalized vaccines and cellular therapies, moving beyond blood cancers into more solid tumors.
  • Greater integration of digital tools, telehealth and remote monitoring, allowing more patient-centric care closer to home.
  • Continued emphasis on survivorship and quality of life measures, ensuring patients live well after treatment.
  • Local access to advanced care and clinical trials, especially through community practices partnering with academic centers.

How Lowcountry Oncology Associates Supports You

At Lowcountry Oncology Associates, we are committed to offering the latest in cancer care, right here in the Charleston area. Whether you are newly diagnosed, in treatment, or in survivorship, our care team strives to bring progress, hope, and partnership to your journey. We believe in keeping you informed about new treatments, supporting your access to care, and empowering you to take an active role.

Final Thoughts

This past year has been a milestone in many ways for cancer care. For you and your loved ones it means more hope, more possibilities, and more reasons to stay engaged in your care. As we move forward together, let’s embrace progress, stay informed about what’s ahead, and remember that every treatment change, every clinical trial, and every patient story contributes to the bigger picture of better care for all.

 

 

Cancer-Related Fatigue: Why Rest Isn’t Always Enough

Cancer-related fatigue is more than feeling tired after a busy day. It is a persistent sense of physical, emotional, or mental exhaustion that can interfere with everyday activities and may not improve with sleep or rest. For people living with cancer, understanding...

Why Pancreatic Cancer Can Be Hard to Detect Early

Pancreatic cancer can be difficult to detect early because it often develops without noticeable symptoms, and there is no recommended routine screening test for people at average risk. Unlike some other cancers, pancreatic cancer may go undetected until it has grown...

Lung Cancer: Why Your Treatment Plan May Look Different From Someone Else’s

A lung cancer treatment plan is not the same for every patient. Even two people diagnosed with lung cancer at a similar time may receive very different recommendations based on the type and stage of their cancer, certain characteristics of their tumor, and their...

Five Common Misconceptions About Cancer Clinical Trials

Cancer clinical trials play an important role in advancing cancer care and may also be a treatment option for eligible patients. However, misconceptions about how they work can make patients hesitant to consider participating. Clinical trials help researchers evaluate...

CAR-T Therapy and Community Oncology: What Expanded Access Means for Patients

Not long ago, CAR-T cell therapy was available only at a handful of major academic medical centers. For patients who needed it, that often meant traveling far from home, staying near a treatment facility for weeks, and navigating a system that felt distant from the...

Liver Cancer Is Often Silent: Why Regular Monitoring Matters for Those at Higher Risk

Liver cancer surveillance can help detect cancer earlier in people who are at higher risk, often before noticeable symptoms develop. Unlike some cancers that may cause warning signs in their early stages, liver cancer can develop quietly. Symptoms may not appear until...